Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Use camera
Select from library
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Goodbye! and best wishes in your recovery
Report by
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

If your report is poison related call 1-800-222-1222 for a free consultation with a live medical poisoning expert

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Ohio, United States

Updated: April 9, 2021 5:54 PM

I am reporting Moderna reaction, Oxford, OH, USA

Symptoms: Nausea Fever Headache Body Ache Muscle Pain
Oxford, OH, USA

April 9, 2021 5:54 PM

“After the second shot. I had fever, nausea, headache, my body throbbed with muscles aching and fever above 100f. It took me almost 36 hrs to recover See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, Whirlpool Corporation, 119 BIRDSEYE ST., CLYDE, OH, 43410, USA

Whirlpool Corporation, 119 BIRDSEYE ST., CLYDE, OH, 43410, USA

April 7, 2021 12:00 PM

“1) Employees are exposed to the hazards of COVID-19 transmission in that the employer does not enforce the company policies on wearing face coverings appropriately. Employees, including line-leaders and supervisors as well as some in upper management, routinely leave their noses uncovered and no dis... See Moreciplinary action is taken.


Source: Osha.gov | Receipt Date: 2021-03-15
See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, Blue Rock Sunoco, aka Green Acres Gas Station, 8635 South River Road, BLUE ROCK, OH, 43720, USA

Blue Rock Sunoco, aka Green Acres Gas Station, 8635 South River Road, BLUE ROCK, OH, 43720, USA

April 7, 2021 12:00 PM

“The employer has not taken the appropriate steps to protect employees from SARS-C0V-2, the virus that causes COVID-19. It was alleged that the employer does not instruct workers who are infected or potentially infected to stay home and isolate or quarantine, does not isolate workers who show symptom... See Mores at work and employees do not wear masks properly.

Alleged Hazards: 1, Employees Exposed: 10
Source: Osha.gov | Receipt Date: 2021-03-15
See Less
Reported By SafelyHQ.com User
Vaccine Side Effects Special summary

Covid-19 OSHA Complaint, Grandad's Pizza, 1254 West 3rd Avenue, COLUMBUS, OH, 43212, USA

Grandad's Pizza, 1254 West 3rd Avenue, COLUMBUS, OH, 43212, USA

April 7, 2021 12:00 PM

“The employer has not taken the appropriate steps to protect employees from SARS-C0V-2, the virus that causes COVID-19. It was alleged that the employer does not instruct workers who are infected or potentially infected to stay home and isolate or quarantine, does not isolate workers who show symptom... See Mores at work and employees do not wear masks properly.

Alleged Hazards: 1, Employees Exposed: 8
Source: Osha.gov | Receipt Date: 2021-03-15
See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, U.S. Postal Service, 2323 City Gate Drive, COLUMBUS, OH, 43218, USA

U.S. Postal Service, 2323 City Gate Drive, COLUMBUS, OH, 43218, USA

April 7, 2021 12:00 PM

“The employer has not taken the appropriate steps to protect employees from SARS-C0V-2, the virus that causes COVID-19. The employer does not instruct workers who are infected or potentially infected to stay home and isolate or quarantine, does not isolate workers who show symptoms at work, and does... See Morenot thoroughly clean and disinfect immediate work areas and equipment used by potentially infected personnel.

Alleged Hazards: 1, Employees Exposed: 200
Source: Osha.gov | Receipt Date: 2021-03-12
See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, Traffic Control Safety Services, Llc, 6769 State Street Northeast, LOUISVILLE, OH, 44641, USA

Traffic Control Safety Services, Llc, 6769 State Street Northeast, LOUISVILLE, OH, 44641, USA

April 7, 2021 12:00 PM

“1. The employer is not enforcing employees to wear masks, which causes potential exposure to COVID-19. 2. The employer is not providing a potable water source to employees.


Source: Osha.gov | Receipt Date: 2021-03-19 See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, United States Postal Service, 333 Erie Street South, MASSILLON, OH, 44646, USA

United States Postal Service, 333 Erie Street South, MASSILLON, OH, 44646, USA

April 7, 2021 12:00 PM

“The employer is not ensuring proper disposal of used COVID-19 personal protective equipment, as there are used masks and gloves throughout the office and work trucks.

Alleged Hazards: 1, Employees Exposed: 10
Source: Osha.gov | Receipt Date: 2021-03-18 See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, RURAL KING OF OHIO, 3541 East Lincoln Way, WOOSTER, OH, 44691, USA

RURAL KING OF OHIO, 3541 East Lincoln Way, WOOSTER, OH, 44691, USA

April 7, 2021 12:00 PM

“The employer is not enforcing the use of face coverings for employees or patrons, which is providing possible exposure to COVID-19.

Alleged Hazards: 1, Employees Exposed: 1
Source: Osha.gov | Receipt Date: 2021-03-15 See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, Town Tavern, 3900 Medina Road, AKRON, OH, 44333, USA

Town Tavern, 3900 Medina Road, AKRON, OH, 44333, USA

April 7, 2021 12:00 PM

“1. Seats have not been separated to 6 feet apart. No barriers between tables. 2. Employees are not wearing masks.

Alleged Hazards: 2, Employees Exposed: 3
Source: Osha.gov | Receipt Date: 2021-02-28 See Less
Reported By SafelyHQ.com User

Covid-19 OSHA Complaint, Cameo Landscaping & Design Inc., 2865 Plum Creek Parkway, CLEVELAND, OH, 44142, USA

Cameo Landscaping & Design Inc., 2865 Plum Creek Parkway, CLEVELAND, OH, 44142, USA

April 7, 2021 12:00 PM

“1. There is no written Hazard Communication Program. 2. Employees are not trained on chemicals and Safety Data Sheets. 3. The employer does not have a Chemical Inventory List. 3. Masks are not being worn by employees or are provided by the ER. 4. Employees are not maintain six feet social distancing... See More.


Source: Osha.gov | Receipt Date: 2021-02-02
See Less
Reported By SafelyHQ.com User

Recent Interesting Reports

I am reporting Pfizer vaccine, Lecompte, LA 71346, USA

Symptoms: Other Headache
Lecompte, LA 71346, USA

March 22, 2021 7:48 PM

“In February I received my 1st dose of Pfizer vaccine and I did get a headache.. yet it was the second dose on March 3 that made me go to the doctor and found that that vaccine has cause me to have high high blood pressure! My numbers doubled and I have not recovered. Now on high blood pressure me... See Moreds. The doctor says I have fluid built up around my heart and palpitations that are driving me to unhappy days.
Letting you know. .
See Less
Reported By SafelyHQ.com User

March 31, 2021 8:00 PM

“Company name: Apotex Corp.
Brand name: Apotex Corp.
Product recalled: Guanfacine Extended-Release Tablets 2mg
Reason of the recall: Trace amounts of Quetiapine Fumarate
FDA Recall date: March 31, 2021
Recall details: Weston, Florida, Apotex Corp is voluntarily recalling three (3) lots of Guanfa... See Morecine Extended-Release Tablets 2mg to the consumer level due to trace amounts of Quetiapine Fumarate in one lot RX1663. Out of an abundance of caution, lots RX1662 and RX1664 are also included in the scope of this voluntary recall, as they were manufactured in the same campaign as lot RX1663.

Risk Statement: Administration of Guanfacine Extended-Release Tablets containing trace amounts of Quetiapine Fumarate to a patient can result in the possibility of hypersensitivity reaction and may potentially have additive effects in lowering blood pressure, sleepiness/sedation, and dizziness. Pediatric patients, pregnant patients and older adults may be more likely to experience low blood pressure and dizziness if exposed to the defective product.

To date, Apotex Corp has not received any reports of adverse events related to this recall. Guanfacine is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and can be used with other stimulant medications. Quetiapine is indicated for the treatment of Schizophrenia and other serious mental disorders such as Bipolar disorder manic episodes, Bipolar disorder, and depressive episodes.

The affected Guanfacine Extended-Release Tablets can be identified by NDC numbers stated on label of the product. The lot number and Expiration date are located to the left side of the product description on the label besides the 2D barcode. The affected lots were distributed in the USA between December 22, 2020 to March 19, 2021.

- Guanfacine Extended-Release Tablets. Pack Size: 100 Tablets. Strength: 2 mg. NDC Number: 60505-3928-1. UPC Code: 3 60505 39281 0. Lot Number / Expiry Date: RX1662 / Nov-22 | RX1663 / Nov-22 | RX1664 / Nov-22

The three (3) affected lots of Guanfacine extended-release tablets were distributed by Apotex nationwide in the USA to Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group. Apotex Corp is currently notifying its affected direct account Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group, via mail (FedEx Standard Overnight) and is arranging for return of all recalled product.

Patients who have received either of the three impacted lots of Guanfacine Extended-Release Tablets or have questions regarding this recall should contact their pharmacy. Individuals should not interrupt their therapy due to this notice. They should immediately contact their health care provider for medical advice and return the impacted product to Inmar Rx Solutions by contacting at the numbers provided in this press release.

Wholesalers, Distributors, Warehousing Chains, Independent Retail Pharmacy and Retail Buying Group should return the recalled product to the place of purchase. Anyone with an existing inventory of the recalled product should quarantine the recalled lots immediately. Customers who purchased the impacted product directly from Apotex can call Inmar Rx Solutions at 1-855-697-4722 (9:00am – 5:00-pm, EST Monday thru Friday), to arrange for their return.

Consumers with the affected units of Guanfacine Extended-Release Tablets, can contact Inmar Rx Solutions (“Inmar”) at 1-855-697-4722, to receive a recall/return packet including the Recall Stock Response Form, or you may obtain this form clsnetlink.comExternal Link Disclaimer

Consumers with questions regarding this recall can contact Apotex Corp. by phone at 1-800-706-5575 (8:30am –5:00pm, EST Monday thru Friday) or email address UScustomerservice@Apotex.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 25, 2021 9:01 AM

“Company name: Sanit Technologies LLC d/b/a Durisan
Brand name: Durisan
Product recalled: Antimicrobial Hand Sanitizer
Reason of the recall: Due to microbial contamination
FDA Recall date: March 24, 2021
Recall details: Sanit Technologies LLC d/b/a Durisan announces a voluntary recall of the lot... See Mores listed in the table below of Durisan Antimicrobial Hand Sanitizer, Non-Alcohol products in various sizes listed. The products are being recalled due to microbial contamination. Specifically, out of specification results for bacterial count for Burkholderia cepacia complex and Ralstonia pickettii. The issue was discovered during a routine audit focused on production scale-up during the height of the pandemic.

Check the link below for the full list of Durisan Antimicrobial Solutions Hand Sanitizer Sizes and Lot Numbers. To date, no reports of adverse reactions or customer complaints have been reported related to this recall.

The product was packaged in sizes ranging from 18mL credit cards, to bottles sized in 118, 236, 300 and 550 mL and 1000mL wall mounted dispenser refills. Pictures are available in the attached related file.

Use of a hand sanitizer contaminated with Burkholderia cepacia complex and Ralstonia pickettii, can range from no reaction to serious infections in a person with a hand wound or scrapes because the bacteria could enter the bloodstream, especially in patients with compromised immune systems. Health care professionals who use this contaminated hand sanitizer and tend to an at-risk patient, such as one with cystic fibrosis, could lead to adverse events ranging from a localized infection to lung or bloodstream infections, which could require patient hospitalization.

The product is intended to be applied topically to help reduce bacteria on the skin that could cause diseases when soap and water are not available. The product can be identified by examples of the product labels below. The product was manufactured from Feb. 1, 2020 until June 30, 2020, and distributed to selected retailers nationwide in the United States.

Durisan has provided written notification to its distributors and retailers and is alerting customers via this voluntary recall. Consumers that have the product which is being recalled are advised to destroy it immediately.

Consumers with questions regarding this recall can contact Durisan at 941-351-9114 [Call: 941-351-9114] , 8:30 am - 4:30 pm Eastern time, Monday through Friday or by e-mail at customerservice@durisan.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using this drug product.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User
Vaccine Side Effects Special summary

Moderna vaccine first shot, Sayville, NY, USA

Symptoms: Numbness Fatigue Soreness
Sayville, NY, USA

April 6, 2021 9:13 PM

“Got my first shot yesterday afternoon at Walgreens. Felt fine most of the evening. Woke up at 1am and my left arm (I had the shot in my left arm) was numb along with the left side of my face. I started to panic thinking great it’s a stroke but I read about temporary Bell’s palsy and calmed down and... See Morewent to sleep. Woke up at 8:30. My arm was very sore which got worse as the day went on, I was very fatigued and had a low fever which Tylenol got rid of. Aches and pains came and went all day. My top lip on my left side of my mouth is still numb and parts of my face feels numb still but I look fine and feel fine otherwise. 30 hours later i would say the worst is the arm pain, I can’t really use my arm. I suggest getting it in your non dominant arm/hand which was suggested to me. Overall the numbness was scary but I think the vaccine is worth it. See Less
Reported By SafelyHQ.com User

Pfizer First Dose Vaccine, Parkland Hospital, Harry Hines Boulevard, Dallas, TX, USA

Symptoms: Headache Fatigue Soreness
Parkland Hospital, Harry Hines Boulevard, Dallas, TX, USA

April 2, 2021 7:33 PM

“The vaccine process went relatively smooth. Waited the recommended 15 minutes for any allergic reactions. Had none. My side effects have been mild. Headache, run down feeling, head fogginess, sore arm from where the vaccine was injected, alittle fatigued, and have noticed my heart rate being alittle... See Moretoo high for comfort. See Less
Reported By SafelyHQ.com User

Johnson and Johnson Vaccine Review, Perth Amboy, NJ, USA

Symptoms: Soreness
Perth Amboy, NJ, USA

April 6, 2021 10:19 PM

“Got the JnJ vaccine Monday morning 4/5/21 at Wegman’s Bridgewater. Other than my arm being a little sore I have no side effects at all. No head aches, no fevers, nothing! SIDE NOTE: I took a COVID test a few days before to confirm I was COVID free before getting vaccinated. I was on Claritin from th... See Moree night before because allergy season has officially started. I didn’t want the Moderna or Pfizer... not a fan of the lipid MRNA. - Stay Safe guys! See Less
Reported By SafelyHQ.com User

April 9, 2021 6:05 PM

“Company name: NS NY Distributor Inc
Brand name: NS NY Distributor Inc
Product recalled: Premium Orgazen 7000 and Ginseng Power 5000 capsules
Reason of the recall: Undeclared Sildenafil and/or Tadalafil
FDA Recall date: April 09, 2021
Recall details: Company Announcement NS NY Distributor Inc is... See Morevoluntarily recalling all lots within expiry of Premium Orgazen 7000 and Ginseng Power 5000 capsules to the consumer level. FDA  analyses has found the products to contain undeclared sildenafil and/or tadalafil. Sildenafil and tadalafil are known as phosphodiesterase (PDE-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction. The presence of sildenafil and/or tadalafil in Premium OrgaZen 7000 and Ginseng Power 5000 makes them unapproved new drugs for which the safety and efficacy have not been established and therefore subject to recall. Consumers with underlying medical issues who take Premium OrgaZen 7000 capsules and Ginseng Power 5000 with undeclared sildenafil and/or tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, NS NY Distributor Inc has not received any reports of adverse events related to this recall. These tainted products are marketed as a dietary supplements for male sexual enhancement and are packaged in a single capsule blister foil sheet and sold in lots of 3 capsules, 5 capsules and 10 capsules. The affected lot numbers of Premium OrgaZen 7000, UPC 0 40232 18144 3, and Ginseng Power 5000, UPC 0 40232 18144 3 include all lots. Premium OrgaZen 7000 and Ginseng Power 5000 were distributed nationwide in the USA via the internet by seller account Beauty.Kor. and fulfilled by amazon at www.amazon.com. NS NY Distributor Inc is notifying customers who purchased through Amazon seller account Beauty.Kor by this press announcement. Consumers that have Premium OrgaZen 7000 and Ginseng Power 5000 which are being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact NS NY Distributors Inc by email at NSNYdistributors@gmail.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online by regular mail or by fax. Complete and submit the report Online
Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User

April 6, 2021 5:00 PM

“Company name: Yolo Studio
Brand name: PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500
Product recalled: Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Tadalafil
FDA Recall date: April 06, 2021
Recall details: Company Announcement Cli... See Moreffside Park, NJ, Yolo Studio is voluntarily recalling all lots of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 to the consumer level. FDA analysis has found the product to contain undeclared tadalafil. Tadalafil is ingredient known as a phosphodiesterase (PDE-5) inhibitor found in FDA approved products for the treatment of male erectile dysfunction. The presence of tadalafil in PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 makes these unapproved new drugs for which the safety and efficacy have not been established and, therefore subject to recall.

Consumers with underlying medical issues who take PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 with undeclared tadalafil may experience serious health risks. For example, PDE- 5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, Yolo Studio has not received any reports of adverse events related to this recall. These tainted products are marketed as dietary supplements for male sexual enhancement and are packaged in cardboard blisters containing one pill per card.

The affected lot numbers of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 include all lots. PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 were distributed via internet and fulfilled by amazon at www.amazon.com nationwide in the USA. On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.

Yolo Studio is notifying its customers by this press announcement and via e-mail of this recall. Consumers that have PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 which are being recalled should stop using and destroy them. Consumers with questions regarding this recall can contact Yolo Studio by phone at (201) 233-3521 Monday through Friday from 9am to 5pm eastern time zone or e-mail yolostudiodamazon@gmail.com.

Consumers should contact their physicians or healthcare provider if they have experienced any problems that may be related to taking or using these drug products. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

- Complete and submit the report Online.
- Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

March 24, 2021 4:00 PM

“Company name: Alembic Pharmaceuticals, Inc.
Brand name: Alembic
Product recalled: Telmisartan Tablets, USP, 20 mg
Reason of the recall: Incorrect Product Strength on Label
FDA Recall date: March 24, 2021
Recall details: Bridgewater, NJ, Alembic Pharmaceuticals, Inc is voluntarily recalling on... See Moree lot of Telmisartan Tablets, USP, 20 mg, packaged in 30-count bottles, Lot No. 1905005661 to the consumer level. The product is being recalled due to a market complaint received which stated that one bottle labelled as 30-count Telmisartan Tablets, USP, 20 mg incorrectly contained 30 tablets of Telmisartan Tablets, USP, 40mg.

Risk Statement: Patients who could be on a doubled dose of telmisartan for a prolonged period of time, could experience low blood pressure, worsening of kidney function, or an elevation of potassium which can be life-threatening. To date, Alembic Pharmaceuticals Limited has not received any reports of adverse events related to this recall. The product is used for the treatment of hypertension i.e. to lower blood pressure and is packaged in a bottle of 30 tablets having NDC Number 62332-087-30.

The affected lot of Telmisartan Tablets, USP, 20 mg is the lot number 1905005661 and the lot expires in March 2022. The wrong product can be identified by checking the shape and embossing details on the tablets i.e. Telmisartan Tablets, USP, 20 mg bottles may incorrectly contain oval shaped White to off-white tablets debossed with L203 on one side instead of correct product i.e. round shaped White to off-white tablets debossed with L 202 on one side. Telmisartan Tablets, USP, 20mg, Lot No. 1905005661 was distributed Nationwide in the USA to wholesalers, retailers, and pharmacies.

Alembic Pharmaceuticals Limited is notifying its distributors and retailers through letter and is arranging for return of the recalled lot. Consumers that may have Telmisartan Tablets, USP, 20 mg which is being recalled should not discontinue use until speaking with their pharmacist or healthcare professional for a replacement before returning to place of purchase. Consumers with questions regarding this recall can contact Alembic Pharmaceuticals Inc by phone at +1 908-552-5839 (9:00 am – 5:00 pm, EDT, Monday through Friday) or email address david.cobb@alembicusa.com.

Check the full recall details on fda.gov

Source: FDA
See Less
Reported By SafelyHQ.com User

April 5, 2021 5:00 PM

“Company name: QMART
Brand name: IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000
Product recalled: Dietary Supplement for male sexual enhancement
Reason of the recall: Undeclared Sildenafil and/or Tadalafil
FDA Recall date: April 05, 2021
Recall det... See Moreails: Company Announcement Elmwood Park, NJ, QMART is voluntarily recalling all lots of IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 to the consumer level. FDA analysis has found the products to be tainted with undeclared sildenafil and/or tadalafil. Sildenafil and tadalafil are ingredients known as phosphodiesterase (PDE-5) inhibitors found in FDA approved products for the treatment of male erectile dysfunction. The presence of sildenafil and/or tadalafil in IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 renders them unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall. Risk Statement: Consumers with underlying medical issues who take IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 capsules with undeclared sildenafil and/or tadalafil may experience serious health risks. For example, PDE-5 inhibitors may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels that may be life-threatening. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. To date, QMART has not received any reports of adverse events related to this recall. These tainted products are marketed as dietary supplements for male sexual performance enhancement and are packaged in cardboard blisters. The affected lots of IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 include all lots. The product can be identified by the UPC codes in the table below which were distributed via internet and fulfilled by amazon at www.amazon.com. On December 17, 2020, FDA issued a press release that warned consumers to avoid certain products found on Amazon, eBay and other retailers due to hidden and potentially dangerous drug ingredients. It also encouraged online marketplaces to ensure these products are not sold on their platforms.
Check the full recall details on fda.gov
Source: FDA
See Less
Reported By SafelyHQ.com User